Axon Enterprise stock has delivered a strong 200.1% return over the past 5 years, but its current checks send mixed valuation signals, with a Discounted Cash Flow (DCF) intrinsic value pointing to a premium while earnings based multiples screen the shares as cheaper than they might first appear.

• A 200.1% gain over 5 years puts Axon Enterprise among the stronger long term performers, which can leave buyers today asking how much of the story is already reflected in the price.
• Recent enthusiasm around revenue growth and contract wins can support higher expectations. However, any disappointment in how those opportunities translate into future cash flows may weigh on what investors are willing to pay.
• Axon Enterprise currently passes just 1 of 6 valuation checks, which leans expensive rather than a clear bargain on the broader framework.

The issue now is whether the current share price already prices in most of Axon Enterprise's growth story or still leaves enough valuation headroom for new investors.

Does Axon Enterprise Look Pricey on Cash Flow?

The Discounted Cash Flow (DCF) approach estimates what Axon Enterprise might be worth today based on projected future cash generation. On this model, Axon’s latest twelve month free cash flow is about $28.7 million, and the projections assume growing cash flows from this base rather than a shrinking business.

Using a 2 Stage Free Cash Flow to Equity model, those projections translate to an estimated intrinsic value of about $451 per share. With the DCF indicating the stock is roughly 20.1% above that level, Axon Enterprise screens as overvalued against this intrinsic value estimate. The recent share price surge, supported by strong revenue growth and an upgraded outlook, helps explain why the market valuation currently sits above what the DCF suggests.

On these cash flow assumptions, Axon Enterprise stock looks overvalued relative to its DCF based intrinsic value estimate.

Our Discounted Cash Flow (DCF) analysis suggests Axon Enterprise may be overvalued by 20.1%. Discover 49 high quality undervalued stocks or create your own screener to find better value opportunities.

Is Axon Enterprise a Bargain on Sales?

P/S is a useful lens for Axon Enterprise because revenue is a key reference point for valuing its subscription and hardware ecosystem. On this measure, Axon trades at a P/S of about 14.6x, which is well above the Aerospace & Defense industry average of 5.1x and also higher than the peer group average of 6.7x.

However, the tailored “fair” P/S ratio for Axon is estimated at around 16.7x, taking into account its specific mix of growth, margins, scale and risk. Compared with that benchmark, the current 14.6x level sits at a discount, suggesting the stock is pricing in less optimism than this framework implies, even after the strong run in Axon Enterprise shares.

On this P/S yardstick, Axon Enterprise stock appears undervalued relative to the multiple implied by its fundamentals and peer context.

The Axon Enterprise Narrative: What Would Justify Today's Price?

Simply Wall St Narratives for Axon Enterprise pick up where the valuation puzzle leaves off by spelling out what would need to be true about Axon Enterprise's future growth, margins and earnings for the stock to be worth materially more or less than today's price, using scenarios that sit on the Community page. Rather than relying on a single multiple or model output, each Narrative lays out the assumptions behind its fair value so you can weigh them against actual results over time.

The community is split on Axon Enterprise, with one camp seeing long term AI and SaaS upside while the other worries rich expectations leave little room for error.

Bull case: 18% undervalued

"Fast-track adoption of new Axon products such as Draft One (AI), TASER 10, Axon Body 4, and Dedrone (counter-drone) is driving up average deal values and product bundles per customer, raising net revenue per user and supporting higher long-term margins as the ecosystem deepens."

Bear case: 26% overvalued

"The rapid commoditization of AI-driven cameras, cloud storage, and real-time analytics threatens to erode Axon's hardware and software competitive advantage, increasing pricing pressure and potentially compressing gross margins as cheaper alternatives become widely available."

Do you think there's more to the story for Axon Enterprise? Head over to our Community to see what others are saying!

The Bottom Line

For Axon Enterprise, the Discounted Cash Flow (DCF) view points to the stock trading above its intrinsic value estimate, while the sales-based multiple suggests it is undervalued relative to its tailored P/S benchmark. That split reflects a tension between cash flow timing and capital needs on one side and growth expectations and sentiment on the other.

The broader valuation checks remain weak despite the supportive P/S signal. The key question is whether Axon Enterprise can convert its revenue opportunities into sustained, cash-rich growth that eventually closes the gap to the current share price.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.